Astaxanthin improves fatty acid dysregulation in diabetes by controlling the AMPK-SIRT1 pathway.

AA level, during the two weeks of therapy with a 10 mg dosage of astaxanthin, revealed a 24 % drop in average levels (from 11.31±0.35 to 8.52±0.72 %), which were statistically highly significant (p-value < 0.01) (Table 2 (Tab. 2) ).

also in 132,142 other papers